GL
Glenmark Pharma
GLENMARK.NS·NSEMumbai INFounded 197715,000 employees
Mid CappharmaPublicDermatologyRespiratory
Platform: Innov Derm
Market Cap
$3B
All Drugs
3
Clinical Trials
6
Failed / Terminated
3
FDA Approved
0
Stock Price & Catalysts (GLENMARK.NS)
Loading GLENMARK.NS stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Rimanesiran | GLE-4024 | Phase 2/3 | 1 | SGLT2 | CholangiocarcinomaMyelofibrosis | ||
| Pemiglumide | GLE-3455 | NDA/BLA | 2 | AuroraA | MM | ||
| Zoriosocimab | GLE-2892 | Phase 3 | 3 | MET | MCCNSCLC |
SEC Filings & Financial Documents
SEC filings are not available for NSE-listed companies.
Glenmark Pharma trades on NSE (IN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (7)